These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11747596)

  • 81. Genetic editing of dysfunctional myocardium.
    Hajjar RJ; Huq F; Matsui T; Rosenzweig A
    Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Apoptosis in heart failure: is there light at the end of the tunnel (TUNEL)?
    Kang PM; Izumo S
    J Card Fail; 2000 Mar; 6(1):43-6. PubMed ID: 10746818
    [No Abstract]   [Full Text] [Related]  

  • 83. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Apoptosis in the failing heart.
    Narula J; Hajjar RJ; Dec GW
    Cardiol Clin; 1998 Nov; 16(4):691-710, ix. PubMed ID: 9891598
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeted gene therapy for the treatment of cardiac dysfunction.
    Askari AT; Penn MS
    Semin Thorac Cardiovasc Surg; 2002 Apr; 14(2):167-77. PubMed ID: 11988956
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Apoptosis in heart failure: a tale of heightened expectations, unfulfilled promises and broken hearts em leader.
    Narula J; Chandrasekhar Y; Dec GW
    Apoptosis; 1998 Oct; 3(5):309-15. PubMed ID: 14646478
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prospects for gene transfer for clinical heart failure.
    Tang T; Gao MH; Hammond HK
    Gene Ther; 2012 Jun; 19(6):606-12. PubMed ID: 22534469
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gene Therapy in Heart Failure.
    Fargnoli AS; Katz MG; Bridges CR; Hajjar RJ
    Handb Exp Pharmacol; 2017; 243():395-421. PubMed ID: 27796512
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gene Therapy for Heart Failure: Back to the Bench.
    Ylä-Herttuala S
    Mol Ther; 2015 Oct; 23(10):1551-2. PubMed ID: 26442799
    [No Abstract]   [Full Text] [Related]  

  • 90. Uniqueness of local myocardial strain patterns with respect to activation time and contractility of the failing heart: a computational study.
    Kirn B; Walmsley J; Lumens J
    Biomed Eng Online; 2018 Dec; 17(1):182. PubMed ID: 30518387
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A semi-quantitative PCR method for the detection of low levels of apoptotic DNA fragmentation in a heart failure model.
    McLachlan CS; Yin JL; Driussi C; Jusuf PR; Hambly B; McGuire MA
    Jpn J Physiol; 2000 Apr; 50(2):281-4. PubMed ID: 10880887
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Gene delivery technologies for cardiac applications.
    Katz MG; Fargnoli AS; Pritchette LA; Bridges CR
    Gene Ther; 2012 Jun; 19(6):659-69. PubMed ID: 22418063
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Molecular cardiology in translation: gene, cell and chemical-based experimental therapeutics for the failing heart.
    Turner I; Belema-Bedada F; Martindale J; Townsend D; Wang W; Palpant N; Yasuda SC; Barnabei M; Fomicheva E; Metzger JM
    J Cardiovasc Transl Res; 2008 Dec; 1(4):317-27. PubMed ID: 19956787
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Emerging Therapeutic Potential Targeting Genetics and Epigentics in Heart Failure.
    Ren J; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1867-1869. PubMed ID: 28601185
    [No Abstract]   [Full Text] [Related]  

  • 95. Assessing Cardiac Contractility From Single Molecules to Whole Hearts.
    Garg A; Lavine KJ; Greenberg MJ
    JACC Basic Transl Sci; 2024 Mar; 9(3):414-439. PubMed ID: 38559627
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy.
    Chelko SP; Keceli G; Carpi A; Doti N; Agrimi J; Asimaki A; Beti CB; Miyamoto M; Amat-Codina N; Bedja D; Wei AC; Murray B; Tichnell C; Kwon C; Calkins H; James CA; O'Rourke B; Halushka MK; Melloni E; Saffitz JE; Judge DP; Ruvo M; Kitsis RN; Andersen P; Di Lisa F; Paolocci N
    Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597260
    [TBL] [Abstract][Full Text] [Related]  

  • 97. High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study.
    Papandreou C; Hernández-Alonso P; Bulló M; Ruiz-Canela M; Li J; Guasch-Ferré M; Toledo E; Clish C; Corella D; Estruch R; Cofán M; Fitó M; Razquin C; Arós F; Fiol M; Santos-Lozano JM; Serra-Majem L; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
    J Nutr; 2020 Nov; 150(11):2882-2889. PubMed ID: 32939552
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Rabbit models of heart disease.
    Pogwizd SM; Bers DM
    Drug Discov Today Dis Models; 2008; 5(3):185-193. PubMed ID: 32288771
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Ribonuclease 1 attenuates septic cardiomyopathy and cardiac apoptosis in a murine model of polymicrobial sepsis.
    Zechendorf E; O'Riordan CE; Stiehler L; Wischmeyer N; Chiazza F; Collotta D; Denecke B; Ernst S; Müller-Newen G; Coldewey SM; Wissuwa B; Collino M; Simon TP; Schuerholz T; Stoppe C; Marx G; Thiemermann C; Martin L
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32213712
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Suppression of phosphorylated MAPK and caspase 3 by carbon dioxide.
    Xu YJ; Elimban V; Dhalla NS
    Mol Cell Biochem; 2017 Dec; 436(1-2):23-28. PubMed ID: 28555276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.